MedTrace Logo

Humor Therapy and Distress After Allogeneic Stem Cell Transplantation

NCT03593161 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2018-07-19

No results posted yet for this study

Summary

This research study evaluates the impact of a humor intervention on distress (primary outcome), hope, depressive symptoms, anxiety, and pain (secondary outcomes) in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT).

Conditions

  • Allogeneic Hematopoietic Stem Cell Transplantation

Interventions

BEHAVIORAL

Humor therapy

Clown visits

Sponsors & Collaborators

  • Deutsche José Carreras Leukämie-Stiftung

    collaborator UNKNOWN

  • Staburo GmbH

    collaborator INDUSTRY

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Nicolaus M. Kröger, Prof. Dr. · University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-08
Primary Completion
2019-08-31
Completion
2019-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03593161 on ClinicalTrials.gov